Halyard Health (NYSE:HYH) posted its quarterly earnings data on Monday. The medical instruments supplier reported $0.73 EPS for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.23, Bloomberg Earnings reports. Halyard Health had a return on equity of 8.65% and a net margin of 3.52%. The firm had revenue of $428.10 million for the quarter, compared to analyst estimates of $413.94 million. During the same quarter last year, the company earned $0.50 EPS. The company’s revenue was up 4.4% on a year-over-year basis.
Shares of Halyard Health (NYSE:HYH) traded down $0.14 during mid-day trading on Tuesday, hitting $48.12. The company’s stock had a trading volume of 211,443 shares, compared to its average volume of 293,441. The firm has a market cap of $2,243.93, a P/E ratio of 40.55, a PEG ratio of 2.52 and a beta of 1.71. Halyard Health has a 52-week low of $35.24 and a 52-week high of $50.99. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.19 and a current ratio of 2.13.
HYH has been the topic of a number of recent research reports. TheStreet lowered Halyard Health from a “b-” rating to a “c+” rating in a research note on Monday, October 30th. Stifel Nicolaus restated a “buy” rating and set a $52.00 price objective on shares of Halyard Health in a research note on Friday, November 3rd. ValuEngine upgraded Halyard Health from a “hold” rating to a “buy” rating in a research note on Saturday, November 4th. Finally, Zacks Investment Research upgraded Halyard Health from a “hold” rating to a “buy” rating and set a $53.00 price objective on the stock in a research note on Wednesday, December 6th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Halyard Health has an average rating of “Buy” and a consensus target price of $49.00.
About Halyard Health
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.